Xylem (XYL)
(Delayed Data from NYSE)
$134.81 USD
-1.49 (-1.09%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $134.84 +0.03 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Income Statements
Fiscal Year end for Xylem Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7,364 | 5,522 | 5,195 | 4,876 | 5,249 |
Cost Of Goods | 4,647 | 3,438 | 3,220 | 3,046 | 3,203 |
Gross Profit | 2,717 | 2,084 | 1,975 | 1,830 | 2,046 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,065 | 1,462 | 1,390 | 1,463 | 1,560 |
Income After Depreciation & Amortization | 652 | 622 | 585 | 367 | 486 |
Non-Operating Income | 32 | -132 | 2 | -5 | -3 |
Interest Expense | 49 | 50 | 76 | 77 | 67 |
Pretax Income | 635 | 440 | 511 | 285 | 416 |
Income Taxes | 26 | 85 | 84 | 31 | 15 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 609 | 355 | 427 | 254 | 401 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 609 | 355 | 427 | 254 | 401 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,088 | 858 | 830 | 676 | 891 |
Depreciation & Amortization (Cash Flow) | 436 | 236 | 245 | 309 | 405 |
Income After Depreciation & Amortization | 652 | 622 | 585 | 367 | 486 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 218.20 | 181.00 | 181.50 | 181.10 | 181.20 |
Diluted EPS Before Non-Recurring Items | 3.78 | 2.85 | 2.49 | 2.06 | 3.02 |
Diluted Net EPS (GAAP) | 2.79 | 1.96 | 2.35 | 1.40 | 2.21 |
Fiscal Year end for Xylem Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,169.00 | 2,033.00 | 2,118.00 | 2,076.00 | 1,722.00 |
Cost Of Goods | 1,350.00 | 1,281.00 | 1,362.00 | 1,312.00 | 1,071.00 |
Gross Profit | 819.00 | 752.00 | 756.00 | 764.00 | 651.00 |
SG&A, R&D, and Dept/Amort Expenses | 566.00 | 543.00 | 545.00 | 573.00 | 532.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 253.00 | 209.00 | 211.00 | 191.00 | 119.00 |
Non-Operating Income | 5.00 | 1.00 | 14.00 | 8.00 | 7.00 |
Interest Expense | 11.00 | 14.00 | 14.00 | 14.00 | 12.00 |
Pretax Income | 247.00 | 196.00 | 210.00 | 185.00 | 114.00 |
Income Taxes | 53.00 | 43.00 | -56.00 | 33.00 | 22.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 194.00 | 153.00 | 266.00 | 152.00 | 92.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 194.00 | 153.00 | 266.00 | 152.00 | 92.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 243.50 | 243.00 | 242.50 | 242.20 | 206.70 |
Diluted EPS Before Non-Recurring Items | 1.09 | 0.90 | 0.99 | 0.99 | 0.98 |
Diluted Net EPS (GAAP) | 0.80 | 0.63 | 1.17 | 0.63 | 0.45 |